-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Bionik Laboratories Corp. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q1 2023.
- Bionik Laboratories Corp. Operating Income (Loss) for the quarter ending March 31, 2023 was -$1.3M, a 7.43% increase year-over-year.
- Bionik Laboratories Corp. Operating Income (Loss) for the twelve months ending March 31, 2023 was -$4.83M, a 51.6% increase year-over-year.
- Bionik Laboratories Corp. annual Operating Income (Loss) for 2022 was -$4.83M, a 51.6% increase from 2021.
- Bionik Laboratories Corp. annual Operating Income (Loss) for 2021 was -$9.97M, a 25.2% increase from 2020.
- Bionik Laboratories Corp. annual Operating Income (Loss) for 2020 was -$13.3M, a 46.8% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)